Molecular diagnostic assay utilizing circulating tumor cell and cell-free DNA analysis to support pulmonary nodule characterization and malignancy risk assessment.
Manufactured by
China
Guangzhou Biotron Technology Co., Ltd. is a Chinese manufacturer of in vitro diagnostic (IVD) products, specializing in molecular diagnostics (multiplex PCR platforms), point-of-care testing (POCT), pathology diagnostics, and tumor liquid biopsy systems. Their product lines include respiratory pathogen detection panels, HPV testing, tuberculosis IGRA assays, and circulating tumor cell (CTC) detection systems. The company also offers CDMO services for diagnostic product development.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Singlera GENOMICS (SHANGHAI) Ltd.
China · 4 relevant products
BioChain (Beijing) Science & Technology. Inc.
China · 1 relevant product
Acon Biotech (Hangzhou) Co., Ltd.
China · 3 relevant products
YASEE BioMedical Inc.
China · 1 relevant product
Shanghai Biotecan pharmaceuticals Co.,Ltd
China · 3 relevant products
HLB PANAGENE Co., Ltd.
South Korea · 7 relevant products
STRATEC/Diatron
Germany · 1 relevant product
Diatech Pharmacogenetics srl
Italy · 2 relevant products
Ease Healthcare
United States · 1 relevant product
Zhuhai Encode Medical Engineering Co Ltd
China · 1 relevant product
47 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →7 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 89 closest product alternatives
Singlera GENOMICS (SHANGHAI) Ltd. · China
A molecular diagnostic test utilizing DNA methylation technology for early detection of lung cancer. Enables risk assessment and early diagnosis of lung malignancies through liquid biopsy methodology.
BioChain (Beijing) Science & Technology. Inc. · China
Advanced early detection test for lung cancer screening utilizing molecular diagnostic technology. This in-development product represents the company's expansion into early detection for pulmonary malignancies. The test is designed for high-risk population screening and clinical intervention.
Acon Biotech (Hangzhou) Co., Ltd. · China
Molecular diagnostic test for cancer detection and tumor marker analysis. Supports early detection of various cancer types.
YASEE BioMedical Inc. · China
Nucleic acid-based diagnostic assay for accurate pathogen and genetic marker detection in clinical and laboratory applications.
Shanghai Biotecan pharmaceuticals Co.,Ltd · China
Molecular diagnostic test providing precise tumor subtyping for improved treatment stratification. Supports personalized oncology management and therapeutic decision-making.
Shanghai Biotecan pharmaceuticals Co.,Ltd · China
High-throughput sequencing detection service for tumor-derived circulating free DNA genetic mutations, enabling precise tumor profiling and monitoring. The service has passed national inter-laboratory quality assessments with full marks.
HLB PANAGENE Co., Ltd. · South Korea
A liquid biopsy diagnostic test for detection of EGFR mutations in circulating tumor DNA, supporting non-invasive lung cancer monitoring and treatment selection.
STRATEC/Diatron · Germany
In-vitro diagnostic test for detecting tumor markers and cancer-related antigens in blood and other biological samples. The test aids in cancer screening, diagnosis, and treatment monitoring.
Diatech Pharmacogenetics srl · Italy
Molecular testing service for monitoring deep response in chronic myeloid leukemia patients from diagnosis through treatment follow-up. Utilizes genomic sequencing and variant analysis to track disease progression and treatment effectiveness.
Singlera GENOMICS (SHANGHAI) Ltd. · China
A molecular diagnostic test based on DNA methylation for early detection and diagnosis of gastric cancer. Supports risk stratification and early screening for gastric malignancies.
Shanghai Biotecan pharmaceuticals Co.,Ltd · China
Molecular diagnostic test for monitoring therapeutic response and detecting minimal residual disease in cancer patients. Supports ongoing treatment optimization and prognosis assessment.
Ease Healthcare · United States
Blood test for assessing lung cancer risk in vulnerable populations, including those with age or smoking history risk factors, enabling early detection and intervention.
77 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products